229 related articles for article (PubMed ID: 23598299)
41. Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer.
Kauko O; Westermarck J
Int J Biochem Cell Biol; 2018 Mar; 96():157-164. PubMed ID: 29355757
[TBL] [Abstract][Full Text] [Related]
42. Molecular Cloning and Developmental Expression Patterns of the Striatin Gene Encoding A Member of the Regulatory Subunits for the Protein Serine/Threonine Phosphatase-2A in Fish.
Xie SS; Luo ZW; Liu FY; Liu L; Chen ZG; Xiang JW; Yang TH; Qi RL; Yang Y; Nie Q; Wang L; Huang Z; Hu XH; Liu YF; Sun Q; Xiao Y; Qing WJ; Liu WB; Liu YZ; Zhang DY; Li DW
Curr Mol Med; 2017; 16(10):923-932. PubMed ID: 28067171
[TBL] [Abstract][Full Text] [Related]
43. PPP2R5B, a regulatory subunit of PP2A, contributes to adipocyte insulin resistance.
Beg M; Srivastava A; Shankar K; Varshney S; Rajan S; Gupta A; Kumar D; Gaikwad AN
Mol Cell Endocrinol; 2016 Dec; 437():97-107. PubMed ID: 27521959
[TBL] [Abstract][Full Text] [Related]
44. Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model.
Bhardwaj A; Singh S; Srivastava SK; Arora S; Hyde SJ; Andrews J; Grizzle WE; Singh AP
Br J Cancer; 2014 Apr; 110(8):2000-10. PubMed ID: 24642616
[TBL] [Abstract][Full Text] [Related]
45. The PP2A-Aβ gene is regulated by multiple transcriptional factors including Ets-1, SP1/SP3, and RXRα/β.
Liu J; Ji W; Sun S; Zhang L; Chen HG; Mao Y; Liu L; Zhang X; Gong L; Deng M; Chen L; Han WJ; Chen PC; Hu WF; Hu X; Woodward Z; Liu WB; Xiao YM; Liang SP; Liu Y; Liu SJ; Li DW
Curr Mol Med; 2012 Sep; 12(8):982-94. PubMed ID: 22827437
[TBL] [Abstract][Full Text] [Related]
46. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
47. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
[TBL] [Abstract][Full Text] [Related]
48. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells.
Kar S; Palit S; Ball WB; Das PK
Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599
[TBL] [Abstract][Full Text] [Related]
49. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
Sangodkar J; Farrington CC; McClinch K; Galsky MD; Kastrinsky DB; Narla G
FEBS J; 2016 Mar; 283(6):1004-24. PubMed ID: 26507691
[TBL] [Abstract][Full Text] [Related]
50. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.
Kuo YC; Huang KY; Yang CH; Yang YS; Lee WY; Chiang CW
J Biol Chem; 2008 Jan; 283(4):1882-92. PubMed ID: 18042541
[TBL] [Abstract][Full Text] [Related]
51. HEAT repeat 1 motif is required for B56γ-containing protein phosphatase 2A (B56γ-PP2A) holoenzyme assembly and tumor-suppressive function.
Nobumori Y; Shouse GP; Fan L; Liu X
J Biol Chem; 2012 Mar; 287(14):11030-6. PubMed ID: 22315229
[TBL] [Abstract][Full Text] [Related]
52. FAM122A, a new endogenous inhibitor of protein phosphatase 2A.
Fan L; Liu MH; Guo M; Hu CX; Yan ZW; Chen J; Chen GQ; Huang Y
Oncotarget; 2016 Sep; 7(39):63887-63900. PubMed ID: 27588481
[TBL] [Abstract][Full Text] [Related]
53. Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors.
O'Connor CM; Leonard D; Wiredja D; Avelar RA; Wang Z; Schlatzer D; Bryson B; Tokala E; Taylor SE; Upadhyay A; Sangodkar J; Gingras AC; Westermarck J; Xu W; DiFeo A; Brautigan DL; Haider S; Jackson M; Narla G
Oncogene; 2020 Jan; 39(3):703-717. PubMed ID: 31541192
[TBL] [Abstract][Full Text] [Related]
54. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
Liu X; Choi RY; Jawad SM; Arnold JT
Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436
[TBL] [Abstract][Full Text] [Related]
55. Protein phosphatase 2A Aα regulates Aβ protein expression and stability.
O'Connor CM; Hoffa MT; Taylor SE; Avelar RA; Narla G
J Biol Chem; 2019 Apr; 294(15):5923-5934. PubMed ID: 30796164
[TBL] [Abstract][Full Text] [Related]
56. Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells.
Kim SW; Kim HJ; Chun YJ; Kim MY
J Toxicol Environ Health A; 2010; 73(21-22):1465-76. PubMed ID: 20954073
[TBL] [Abstract][Full Text] [Related]
57. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
[TBL] [Abstract][Full Text] [Related]
58. Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer.
Cristóbal I; González-Alonso P; Daoud L; Solano E; Torrejón B; Manso R; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Mar Drugs; 2015 May; 13(6):3276-86. PubMed ID: 26023836
[TBL] [Abstract][Full Text] [Related]
59. The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation.
Reid MA; Wang WI; Rosales KR; Welliver MX; Pan M; Kong M
Mol Cell; 2013 Apr; 50(2):200-11. PubMed ID: 23499005
[TBL] [Abstract][Full Text] [Related]
60. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
